Navamedic ASA: Q1 2019 financial results

Oslo, 15 May 2019 – Navamedic ASA (OSE: NAVA) reported revenues of NOK 45.5 million in the first quarter of 2019, up 6.6% from the same period in 2018, and improved EBITDA of NOK -2.0 million (-5.0). During the first quarter of 2019, the new Board of Directors and the new CEO of Navamedic started implementing the growth strategy and see a strong potential in the company’s highly scalable market access platform.  

“We have initiated the implementation of the new growth strategy and see a great potential in leveraging Navamedic’s highly scalable pharma market access platform. In the first

Source: Navamedic ASA: Q1 2019 financial results

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.